Research Alert: CFRA Reiterates Sell Opinion On Shares Of Adient Plc
CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lower our 12-month target by $2 to $
Adient Posts Wider Loss In Q2, Cuts FY24 Guidance; Stock Falls
Adient (ADNT.US): The 2024 Q2 financial report achieved revenue of US$3.75 billion, with a previous value of US$3,912 billion, with an expected value of US$3.79 billion; earnings per share were US$0.54, the previous value was US$0.32, and the expected val
Adient (ADNT.US): The 2024 Q2 financial report achieved revenue of US$3.75 billion, with a previous value of US$3,912 billion, with an expected value of US$3.79 billion; earnings per share were US$0.54, the previous value was US$0.32, and the expected value was US$0.42.
Adient Lowers FY24 Sales Outlook To $14.8B-$14.9B From $15.4B-$15.5B (Estimate: $15.47B), Sees Adjusted EBITDA Between $900M-$920M From $985M
Adient Lowers FY24 Sales Outlook To $14.8B-$14.9B From $15.4B-$15.5B (Estimate: $15.47B), Sees Adjusted EBITDA Between $900M-$920M From $985M
Adient Q2 Adj $0.54 Beats $0.42 Estimate, Adj. EBITDA Totals $227M, Up By $12M YoY
Adient (NYSE:ADNT) reported quarterly earnings of $0.54 per share which beat the analyst consensus estimate of $0.42 by 28.57 percent. This is a 68.75 percent increase over earnings of $0.32 per share
Adient 2Q EPS 77c >ADNT
Adient 2Q EPS 77c >ADNT
Calendar of U.S. Earnings Expected in the Week Ahead
Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc. Company Symbo
Earnings Preview: Adient to Report Financial Results Pre-market on May 03
$Adient(ADNT.US)$ is scheduled to release its financial results pre-market on May 03. Earnings PreviewAnalysts estimate $Adient(ADNT.US)$ to post revenue of USD3.79 billion for 2024Q2, down 3.19% YoY;
We Think Adient (NYSE:ADNT) Is Taking Some Risk With Its Debt
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says 'The biggest investment risk is not the volatility of prices, but whether you will
Automotive Seating Maker Adient To Slash Jobs In Europe
Adient PLC (NYSE:ADNT) has put forward restructuring plans in Europe to reduce operating, administrative and engineering costs.
Adient Is Maintained at Neutral by JP Morgan
Adient Is Maintained at Neutral by JP Morgan
Komo: Maintaining the Adient (ADNT.US) rating, adjusted from neutral to neutral, and adjusted the target price from $40.00 to $37.00.
Komo: Maintaining the Adient (ADNT.US) rating, adjusted from neutral to neutral, and adjusted the target price from $40.00 to $37.00.
JP Morgan Maintains Neutral on Adient, Lowers Price Target to $37
JP Morgan analyst Ryan Brinkman maintains Adient with a Neutral and lowers the price target from $40 to $37.
Auto Supplier Adient Cuts Jobs, Transfers Roles in Europe to Shave Costs
Adient to Reduce Workforce, Move Jobs Out of Europe Under Restructuring Plans
Adient (ADNT) said in a regulatory filing Monday that it is implementing restructuring plans in Europe aimed at reducing operating, administrative and engineering costs, mainly through job cuts and mo
On April 22, 2024, Adient Reveals Restructuring Plans In Europe To Reduce Costs, Primarily Through Workforce Reductions - Filing
The plans were initiated by Adient's management as of March 31, 2024, and the affected employees were notified earlier today. Adient currently expects to record a restructuring charge of approximately
Adient (NYSE:ADNT Shareholders Incur Further Losses as Stock Declines 4.5% This Week, Taking Three-year Losses to 34%
Shares of Companies Within the Auto and Auto Components Sector Are Trading Lower Amid Overall Market Weakness Following Hotter-than-expected March Inflation Data.
Shares of Companies Within the Auto and Auto Components Sector Are Trading Lower Amid Overall Market Weakness Following Hotter-than-expected March Inflation Data.
Adient Cut to Equal-Weight From Overweight by Barclays
Adient Cut to Equal-Weight From Overweight by Barclays
Barclays Downgrades Adient to Equal-Weight, Lowers Price Target to $37
Barclays analyst Dan Levy downgrades Adient from Overweight to Equal-Weight and lowers the price target from $41 to $37.
No Data